Silodosin versus tamsulosin in symptomatic benign prostatic hyperplasia-Our experience

Abstract

Aim: Benign prostatic hyperplasia (BPH) is the most common cause of lower urinary tract symptoms in elderly men. Selective alfa 1 -adrenergic antagonists are now first-line drugs in the medical management of BPH. We conducted randomized, controlled trial to compare the effectiveness and safety of the new alfa 1 -blocker silodosin versus the established drug… (More)

Topics

  • Presentations referencing similar topics